Medications for Diabetes and Weight Loss May Increase Risk of Cognitive Impairment, New Study Warns
Glucagon-like peptide-1 (GLP-1) receptor agonists have transformed the treatment landscape for type 2 diabetes and obesity, offering significant benefits in blood sugar control and weight reduction. However, as their use expands globally, questions are emerging about potential long-term effects on brain health. Recent research suggests a complex relationship between these medications and cognitive function, warranting … Read more